Key Insights

Highlights

Success Rate

88% trial completion (above average)

Published Results

36 trials with published results (17%)

Research Maturity

121 completed trials (58% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

8.1%

17 terminated out of 210 trials

Success Rate

87.7%

+1.2% vs benchmark

Late-Stage Pipeline

15%

32 trials in Phase 3/4

Results Transparency

30%

36 of 121 completed with results

Key Signals

36 with results88% success17 terminated

Data Visualizations

Phase Distribution

135Total
Not Applicable (66)
Early P 1 (1)
P 1 (11)
P 2 (25)
P 3 (13)
P 4 (19)

Trial Status

Completed121
Unknown24
Recruiting21
Terminated17
Active Not Recruiting10
Withdrawn9

Trial Success Rate

87.7%

Benchmark: 86.5%

Based on 121 completed trials

Clinical Trials (210)

Showing 20 of 20 trials
NCT07119229Not ApplicableRecruiting

A Multi Center Study Testing a New Implant for Adults With Severe Emphysema

NCT07086339Not ApplicableRecruiting

A Trial of the Implantable Artificial Bronchus 50 Flex in Patients With Severe Emphysema

NCT07592637Not ApplicableNot Yet RecruitingPrimary

Lung Disease and FLNA Mutations

NCT06533371Not ApplicableRecruitingPrimary

Clinical-ultrasonographic Assessment of Pulmonary Emphysema

NCT07326592Phase 4Not Yet Recruiting

Phase 4, Double-blind Study Evaluating the Response on Computed Tomography (CT) Lung Density Decline Rates of Respreeza / Zemaira Weekly for 3 Years in Adults With alpha1 Antitrypsin Deficiency (AATD)

NCT05567562Phase 2Completed

Anti-Platelets in Chronic Obstructive Pulmonary Disease

NCT06025500RecruitingPrimary

Analysing Peripheral Skeletal Muscle Function Before and After Endobronchial Valve Treatment

NCT04302272RecruitingPrimary

STRIVE Post-Market Registry Study

NCT06891755Not ApplicableRecruiting

Bronchoscopic RElease of Air Trapped in Hyperinflated Emphysematous Lung - Study 3

NCT00843271Active Not Recruiting

Endothelial Dysfunction, Biomarkers, and Lung Function -Ancillary to MESA

NCT05897424Phase 2Active Not Recruiting

Long-term, Open-label Study of SAR447537 (INBRX-101) in Adults With Alpha-1 Antitrypsin Deficiency Emphysema

NCT05087641Not ApplicableActive Not RecruitingPrimary

A Multicenter, Prospective Trial of the IAB in Adults Suffering From COPD/Emphysema

NCT05550844CompletedPrimary

Emphysema and FLNA Mutation (E-FLNA)

NCT07403617Not ApplicableNot Yet RecruitingPrimary

Ventilation-Perfusion Discrepancy Index Versus Conventional Anatomic-Physiologic Assessment for Target Lung Lobe Selection in Endobronchial Valve Placement: A Multicenter, Randomised Controlled Trial

NCT05382208Phase 2Active Not RecruitingPrimary

Doxycycline for Emphysema in People Living With HIV (The DEPTH Trial)

NCT02439528Not ApplicableCompleted

Genetics of the Combined Pulmonary Fibrosis and Emphysema Syndrome

NCT01969344Active Not Recruiting

Study of COPD Subgroups and Biomarkers

NCT07059637Not ApplicableRecruiting

Implementation of a Sarcopenia Clinic to Diagnose and Treat Skeletal Muscle Loss Due to COPD

NCT00307281RecruitingPrimary

Emphysema Research Registry and Biosample Repository

NCT00608764Active Not Recruiting

Examining the Genetic Factors That May Cause Chronic Obstructive Pulmonary Disease (COPD)

Scroll to load more

Research Network

Activity Timeline